Table 5.
Mean difference in growth measures for lower vs. highest quartiles of respective fatty acid proportions among 6–10 years old Ugandan children with and without Perinatal HIV infection 1.
| Fatty Acid | HAZ | WAZ | BAZ | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | HIV*FA2 | Q1 | Q2 | Q3 | HIV*FA | Q1 | Q2 | Q3 | HIV*FA | |
| Palmitic | 0.29 (0.166) | 0.00 (0.973) | −0.03 (0.862) | 0.283 | 0.27 (0.183) | 0.12 (0.526) | 0.15 (0.416) | 0.365 | 0.14 (0.495) | 0.12 (0.532) | 0.26 (0.162) | 0.475 |
| Total SFA | 0.30 (0.126) | 0.18 (0.385) | −0.18 (0.332) | 0.984 | 0.27 (0.137) | 0.27 (0.165) | −0.15 (0.354) | 0.813 | 0.14 (0.490) | 0.26 (0.178) | −0.02 (0.893) | 0.481 |
| Oleic | 0.35 (0.055) | 0.45 (0.043) | 0.38 (0.020) | 0.101 | 0.34 (0.049) | 0.51 (0.011) | 0.46 (0.008) | 0.051 | 0.20 (0.222) | 0.50 (0.002) | 0.37 (0.035) | 0.088 |
| Eicosenoic | 0.34 (0.108) | 0.01 (0.981) | −0.21 (0.233) | 0.905 | 0.31 (0.121) | 0.12 (0.528) | 0.00 (0.986) | 0.523 | 0.18 (0.393) | 0.19 (0.326) | 0.22 (0.242) | 0.318 |
| Mead acid | 0.33 (0.074) | 0.06 (0.763) | −0.09 (0.632) | 0.183 | 0.33 (0.086) | 0.22 (0.197) | 0.07 (0.725) | 0.628 | 0.22 (0.270) | 0.29 (0.087) | 0.20 (0.331) | 0.412 |
| Nervonic | 0.23 (0.282) | 0.08 (0.707) | −0.03 (0.865) | 0.275 | 0.14 (0.475) | 0.03 (0.897) | 0.06 (0.747) | 0.547 | −0.05 (0.779) | −0.08 (0.699) | 0.10 (0.621) | 0.548 |
| Total MUFA | 0.31 (0.075) | 0.52 (0.005) | 0.17 (0.322) | 0.850 | 0.26 (0.146) | 0.61 (0.001) | 0.28 (0.107) | 0.500 | 0.09 (0.678) | 0.46 (0.020) | 0.29 (0.134) | 0.592 |
| EPA | −0.19 (0.342) | −0.42 (0.028) | −0.38 (0.077) | 0.164 | 0.10 (0.618) | −0.14 (0.469) | −0.29 (0.170) | 0.562 | 0.31 (0.103) | 0.22 (0.253) | −0.10 (0.253) | 0.766 |
| DHA | −0.42 (0.038) | −0.08 (0.691) | 0.12 (0.559) | 0.811 | −0.39 (0.029) | −0.06 (0.747) | 0.07 (0.706) | 0.400 | −0.21 (0.202) | −0.06 (0.743) | −0.02 (0.922) | 0.225 |
| Total n-3 | −0.45 (0.029) | −0.13 (0.515) | −0.23 (0.223) | 0.546 | −0.32 (0.097) | −0.10 (0.586) | −0.23 (0.220) | 0.517 | −0.07 (0.951) | −0.05 (0.755) | −0.14 (0.485) | 0.506 |
| Linoleic | −0.43 (0.005) | −0.08 (0.380) | −0.21 (0.162) | 0.349 | −0.38 (0.028) | 0.06 (0.688) | −0.01 (0.954) | 0.244 | −0.15 (0.445) | 0.18 (0.311) | 0.19 (0.336) | 0.482 |
| Eicosadienoic | 0.21 (0.261) | 0.00 (0.993) | 0.22 (0.260) | 0.905 | 0.38 (0.038) | 0.24 (0.182) | 0.30 (0.144) | 0.221 | 0.38 (0.047) | 0.35 (0.046) | 0.22 (0.296) | 0.398 |
| Total n-6 | −0.31 (0.111) | −0.43 (0.019) | −0.14 (0.522) | 0.613 | −0.29 (0.113) | −0.28 (0.100) | −0.08 (0.676) | 0.395 | −0.16 (0.391) | −0.01 (0.961) | 0.04 (0.870) | 0.129 |
| Total PUFA | −0.33 (0.088) | −0.45 (0.012) | −0.13 (0.572) | 0.873 | −0.30 (0.117) | −0.31 (0.071) | 0.03 (0.901) | 0.908 | −0.13 (0.501) | −0.05 (0.794) | 0.18 (0.351) | 0.828 |
1 β-coefficient (p-value) presented for comparisons of lower FA quartiles (Q1–Q3) vs. the highest quartile (Q4). FA, fatty acid; SFA, saturated FA; MUFA, monounsaturated FA; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; n-3, omega-3; n-6, omega-6; PUFA, polyunsaturated FA. 2 P-value for interaction term between HIV status and FA quartile presented. Bolding indicates statistical significance (p < 0.05).